57
edits
Difference between revisions of "Phage therapy"
Jump to navigation
Jump to search
no edit summary
| Line 1: | Line 1: | ||
'''The isolation, characterization and pre-clinical screening of novel bacteriophages as therapies for antibiotic resistant, sexually-transmitted bacterial infections'''. | '''The isolation, characterization and pre-clinical screening of novel bacteriophages as therapies for antibiotic resistant, sexually-transmitted bacterial infections'''. | ||
''Next Call: 1/20/12 8:00pm PST/10:00pm CST'' (meeting notes available[http://shrib.com/phage_therapy] | ''Next Call: 1/20/12 8:00pm PST/10:00pm CST'' (meeting notes available[http://shrib.com/phage_therapy here]. | ||
'''Discussion Topics Include''': | '''Discussion Topics Include''': | ||
| Line 9: | Line 9: | ||
* Lytic phage kill; Lysogenic incorporate in host genome then wait for opportunity to become lytic! | * Lytic phage kill; Lysogenic incorporate in host genome then wait for opportunity to become lytic! | ||
* What if we could activate phage lytic life cycle with non-antibiotic molecules? | * What if we could activate phage lytic life cycle with non-antibiotic molecules? | ||
* | * [http://www.youtube.com/watch?v=YJWKWYQfSi0/ Quorum Sensing] | ||
*Methods of Phage Isolation and Characterization | *Methods of Phage Isolation and Characterization | ||
*"Isolation and Characterization of Bacteriophages for Neisseria" L.N. Phelps, J. gen. Virol (1967) 1, 529-532. | *"Isolation and Characterization of Bacteriophages for Neisseria" L.N. Phelps, J. gen. Virol (1967) 1, 529-532. | ||